Edith P. Mitchell

18.3k total citations · 4 hit papers
205 papers, 12.1k citations indexed

About

Edith P. Mitchell is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Edith P. Mitchell has authored 205 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Oncology, 66 papers in Pulmonary and Respiratory Medicine and 43 papers in Surgery. Recurrent topics in Edith P. Mitchell's work include Colorectal Cancer Treatments and Studies (87 papers), Cancer Treatment and Pharmacology (42 papers) and Lung Cancer Treatments and Mutations (28 papers). Edith P. Mitchell is often cited by papers focused on Colorectal Cancer Treatments and Studies (87 papers), Cancer Treatment and Pharmacology (42 papers) and Lung Cancer Treatments and Mutations (28 papers). Edith P. Mitchell collaborates with scholars based in United States, Canada and Netherlands. Edith P. Mitchell's co-authors include Neal J. Meropol, Al B. Benson, Steven R. Alberts, Peter J. O’Dwyer, Paul J. Catalano, Bruce J. Giantonio, Michael Schwartz, Nicholas Iannotti, Steven J. Cohen and Michael Craig Miller and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Edith P. Mitchell

195 papers receiving 11.7k citations

Hit Papers

Bevacizumab in Combination With Oxaliplatin, Fluorouracil... 2007 2026 2013 2019 2007 2008 2007 2008 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
    2007 1.7k citations Bruce J. Giantonio, Neal J. Meropol et al. Journal of Clinical Oncology profile →
  2. Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer
    2008 1.5k citations Steven J. Cohen, Cornelis J.A. Punt et al. Journal of Clinical Oncology profile →
  3. Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study
    2007 665 citations Edith P. Mitchell et al. Journal of Clinical Oncology profile →
  4. A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer
    2008 644 citations Edith P. Mitchell et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edith P. Mitchell United States 47 8.8k 3.6k 2.7k 2.4k 1.7k 205 12.1k
Timothy Price Australia 48 10.7k 1.2× 5.0k 1.4× 2.3k 0.9× 2.8k 1.2× 2.8k 1.6× 476 14.8k
Christos S. Karapetis Australia 42 8.2k 0.9× 3.8k 1.1× 2.3k 0.8× 2.0k 0.8× 1.6k 1.0× 314 11.2k
Kristine Broglio United States 52 7.2k 0.8× 2.6k 0.7× 4.3k 1.6× 1.9k 0.8× 1.4k 0.8× 148 12.3k
Eduardo Díaz‐Rubio Spain 49 8.7k 1.0× 3.5k 1.0× 2.0k 0.7× 2.0k 0.8× 2.4k 1.4× 351 12.0k
Howard S. Höchster United States 56 8.1k 0.9× 3.3k 0.9× 1.8k 0.7× 2.4k 1.0× 1.8k 1.1× 342 12.0k
Jonathan A. Ledermann United Kingdom 60 9.2k 1.0× 2.2k 0.6× 2.2k 0.8× 4.9k 2.1× 3.1k 1.8× 295 17.4k
Tanios Bekaii‐Saab United States 58 8.1k 0.9× 3.3k 0.9× 2.3k 0.8× 3.1k 1.3× 4.0k 2.4× 569 12.7k
Niall C. Tebbutt Australia 48 9.3k 1.0× 4.4k 1.2× 2.0k 0.7× 2.7k 1.1× 3.0k 1.8× 255 12.8k
Yasuhide Yamada Japan 55 5.3k 0.6× 3.8k 1.0× 1.9k 0.7× 4.3k 1.8× 1.6k 1.0× 308 10.9k
Brigette Ma Hong Kong 53 4.9k 0.5× 2.3k 0.6× 2.4k 0.9× 2.7k 1.1× 2.3k 1.4× 243 10.2k

Countries citing papers authored by Edith P. Mitchell

Since Specialization
Citations

This map shows the geographic impact of Edith P. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith P. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith P. Mitchell more than expected).

Fields of papers citing papers by Edith P. Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edith P. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith P. Mitchell. The network helps show where Edith P. Mitchell may publish in the future.

Co-authorship network of co-authors of Edith P. Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Edith P. Mitchell. A scholar is included among the top collaborators of Edith P. Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edith P. Mitchell. Edith P. Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ballinger, Tarah J., Fengmin Zhao, Joseph A. Sparano, et al.. (2024). ECOG-ACRIN EAZ171: Prospective validation trial of germline variants and taxane type in association with taxane-induced peripheral neuropathy (TIPN) in Black women with early-stage breast cancer.. Journal of Clinical Oncology. 42(17_suppl). LBA503–LBA503. 1 indexed citations
2.
Dotan, Efrat, et al.. (2024). Disparities in care of older adults of color with cancer: A narrative review. Cancer Medicine. 13(3). e6790–e6790. 4 indexed citations
3.
Stearns, Vered, Opeyemi A. Jegede, Victor T. Chang, et al.. (2024). A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11. Clinical Cancer Research. 30(13). 2709–2718. 4 indexed citations
4.
Schabath, Matthew B., et al.. (2024). Medical student clinical cultural awareness in cancer care of sexual gender minority patients. Patient Education and Counseling. 129. 108395–108395. 1 indexed citations
5.
Young, Michal, et al.. (2024). A review of dairy food intake for improving health among black children and adolescents in the US. Journal of the National Medical Association. 116(2). 241–252.
6.
Nelson, Nicolas G., et al.. (2023). Physician Perceptions on Cancer Screening for LGBTQ+ Patients. Cancers. 15(11). 3017–3017. 1 indexed citations
7.
Newman, Lisa A. & Edith P. Mitchell. (2023). Disparities in triple negative breast cancer. Journal of the National Medical Association. 115(2). S8–S12.
8.
Mitchell, Edith P., Lynne I. Wagner, Melissa A. Simon, et al.. (2022). “I need more knowledge”: Qualitative analysis of oncology providers’ experiences with sexual and gender minority patients. Frontiers in Psychology. 13. 763348–763348. 10 indexed citations
9.
Savitch, Samantha L., Tyler R. Grenda, Scott W. Cowan, et al.. (2020). Racial Disparities in Rates of Surgery for Esophageal Cancer: a Study from the National Cancer Database. Journal of Gastrointestinal Surgery. 25(3). 581–592. 32 indexed citations
10.
Mitchell, Edith P., et al.. (2020). Clinical presentations and outcomes in pulmonary embolism patients with cancer. Journal of Thrombosis and Thrombolysis. 51(2). 430–436. 9 indexed citations
11.
Johnson, Douglas B., Fengmin Zhao, Marcus Smith Noel, et al.. (2020). Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131). Clinical Cancer Research. 26(8). 1812–1819. 42 indexed citations
12.
Mitchell, Edith P.. (2020). Declines in Cancer Screening During COVID-19 Pandemic. Journal of the National Medical Association. 112(6). 563–564. 26 indexed citations
13.
14.
Parikh, Aparna R., Fa-Chyi Lee, Linda Yau, et al.. (2018). MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer. Clinical Cancer Research. 25(10). 2988–2995. 39 indexed citations
15.
Bernard, Brandon, Vinayak Muralidhar, Yu‐Hui Chen, et al.. (2017). Impact of ethnicity on the outcome of men with metastatic, hormone‐sensitive prostate cancer. Cancer. 123(9). 1536–1544. 56 indexed citations
16.
Cutsem, Eric Van, Cathy Eng, Elżbieta Nowara, et al.. (2014). Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type KRAS Metastatic Colorectal Cancer. Clinical Cancer Research. 20(16). 4240–4250. 92 indexed citations
17.
Wong, Stuart J., Jennifer Moughan, Neal J. Meropol, et al.. (2014). Efficacy Endpoints of Radiation Therapy Group Protocol 0247: A Randomized, Phase 2 Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 91(1). 116–123. 27 indexed citations
18.
19.
Cohen, Steven J., Cornelis J.A. Punt, Nicholas Iannotti, et al.. (2008). Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer. Journal of Clinical Oncology. 26(19). 3213–3221. 1473 indexed citations breakdown →
20.
Eiseman, Andrew S., et al.. (2003). Ocular Surface, Ocular Adnexal, and Lacrimal Complications Associated With the Use of Systemic 5-Fluorouracil. Ophthalmic Plastic and Reconstructive Surgery. 19(3). 216–224. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy Price Breakdown of academic impact, for papers by Christos S. Karapetis Breakdown of academic impact, for papers by Kristine Broglio Breakdown of academic impact, for papers by Eduardo Díaz‐Rubio Breakdown of academic impact, for papers by Howard S. Höchster Breakdown of academic impact, for papers by Jonathan A. Ledermann Breakdown of academic impact, for papers by Tanios Bekaii‐Saab Breakdown of academic impact, for papers by Niall C. Tebbutt Breakdown of academic impact, for papers by Yasuhide Yamada Breakdown of academic impact, for papers by Brigette Ma
Rankless by CCL
2026